[go: up one dir, main page]

FI970143A0 - Kinoliinijohdannaiset leukotrieeniantagonisteina - Google Patents

Kinoliinijohdannaiset leukotrieeniantagonisteina

Info

Publication number
FI970143A0
FI970143A0 FI970143A FI970143A FI970143A0 FI 970143 A0 FI970143 A0 FI 970143A0 FI 970143 A FI970143 A FI 970143A FI 970143 A FI970143 A FI 970143A FI 970143 A0 FI970143 A0 FI 970143A0
Authority
FI
Finland
Prior art keywords
quinoline derivatives
leukotriene antagonists
leukotriene
antagonists
quinoline
Prior art date
Application number
FI970143A
Other languages
English (en)
Swedish (sv)
Other versions
FI970143A7 (fi
Inventor
Dorte Kirstein
Schneur Rachlin
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI970143A0 publication Critical patent/FI970143A0/fi
Publication of FI970143A7 publication Critical patent/FI970143A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
FI970143A 1994-07-20 1997-01-14 Kinoliinijohdannaiset leukotrieeniantagonisteina FI970143A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414590A GB9414590D0 (en) 1994-07-20 1994-07-20 Chemical compounds
PCT/DK1995/000223 WO1996002506A1 (en) 1994-07-20 1995-06-07 Quinoline derivatives as leukotriene antagonists

Publications (2)

Publication Number Publication Date
FI970143A0 true FI970143A0 (fi) 1997-01-14
FI970143A7 FI970143A7 (fi) 1997-01-14

Family

ID=10758585

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970143A FI970143A7 (fi) 1994-07-20 1997-01-14 Kinoliinijohdannaiset leukotrieeniantagonisteina

Country Status (13)

Country Link
EP (1) EP0773931A1 (fi)
JP (1) JPH10504026A (fi)
KR (1) KR970704691A (fi)
CN (1) CN1152915A (fi)
AU (1) AU686820B2 (fi)
CA (1) CA2192478A1 (fi)
CZ (1) CZ284799B6 (fi)
FI (1) FI970143A7 (fi)
GB (1) GB9414590D0 (fi)
HU (2) HU9603342D0 (fi)
NZ (1) NZ287850A (fi)
PL (1) PL318106A1 (fi)
WO (1) WO1996002506A1 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761687B1 (fr) 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
US4918081A (en) * 1988-06-20 1990-04-17 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene d4
GB9216768D0 (en) * 1992-08-07 1992-09-23 Leo Pharm Prod Ltd Chemical compounds

Also Published As

Publication number Publication date
AU2669695A (en) 1996-02-16
PL318106A1 (en) 1997-05-12
JPH10504026A (ja) 1998-04-14
CZ284799B6 (cs) 1999-03-17
AU686820B2 (en) 1998-02-12
EP0773931A1 (en) 1997-05-21
HUT76443A (en) 1997-09-29
CZ352996A3 (en) 1997-10-15
NZ287850A (en) 1998-05-27
FI970143A7 (fi) 1997-01-14
KR970704691A (ko) 1997-09-06
GB9414590D0 (en) 1994-09-07
WO1996002506A1 (en) 1996-02-01
CN1152915A (zh) 1997-06-25
CA2192478A1 (en) 1996-02-01
HU9603342D0 (en) 1997-01-28

Similar Documents

Publication Publication Date Title
FI944734A7 (fi) Kinoliinijohdannaiset leukotrieeniantagonisteina
NO965036L (no) Kinolinderivater som techykinin NK3 reseptor-antagonister
NO20013003D0 (no) Kinolin-derivater
ATE250036T1 (de) Chinolinderivate
DK1073639T3 (da) Chinolinderivater
NO20013088D0 (no) 1,2-annelerte kinolinderivater
DE69634416D1 (de) Chinolin-derivate
FI970310L (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
ATE229005T1 (de) Chinolinderivate
DK0922034T3 (da) Tetrahydroquinolinderivater som EAA-antagonister
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
NO974043L (no) Indolderivater som EAA-antagonister
DK0854867T3 (da) Tetrahydroquinoliner som NMDA-antagonister
DK1216250T3 (da) Thienoisoxazolyl- og thienylpyrazolyl-phenoxy- substituerede propylderivater som D4-antagonister
FI962639A0 (fi) Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina
DK1086093T3 (da) Tetrahydroquinolinderivater som glycinantagonister
FI970745A7 (fi) Dihydropyridiinijohdannaisia bradykiiniantagonisteina
ITMI941099A0 (it) Derivati chinolinici
FI971492L (fi) Indolijohdannaiset 5-HT1-tyyppisinä agonisteina
FI970143A0 (fi) Kinoliinijohdannaiset leukotrieeniantagonisteina
NO983656D0 (no) Heterocyklyl-ergolinderivater som 5-HT1A reseptorligander
DE69515498D1 (de) Naphthyridinderivate
KR950700884A (ko) 루코트리엔 길항제로서의 퀴놀린 유도체(Quinoline derivatives as leukotriene antagonists)
NO920022L (no) Umettede hydroksyalkylkinolinsyrer som leukotrienantagonister
ITMI941098A0 (it) Derivati chinolinici